Sommario

• • ·Editorial Board

    Articolo :100632

    
• • ·Content

    Articolo :100633

    

• Editorial

  • ·Eligibility of men vs. women in Alzheimer’s trials: Inclusive vs. representative

    Articolo :100625

    Joshua D. Grill, Daniel L. Gillen

    Mappa Mappa

• Original article

  • ·Top five Alzheimer Disease trial eligibility criteria favor men compared to women in a clinic-based cohort

    Articolo :100580

    Lieza G. Exalto, Siti S. Syaziyah, Xiaotian T Fang, Niels D. Prins, Sietske A.M. Sikkes, Wiesje M. van der Flier, Everard G.B. Vijverberg, Yvonne M.F. Lim

    Riassunto Riassunto Mappa Mappa   

• Editorial

  • ·Beyond target engagement: RNA therapeutics and the neuroimmune challenge in tauopathies

    Articolo :100626

    Elizabeth Anne Breen

    Riassunto Riassunto Mappa Mappa

• Review

  • ·RNA-based therapeutics for Alzheimer’s disease and related tauopathies: challenges and opportunities

    Articolo :100585

    Binita Rajbanshi, Ilaria Brentari, Michela Alessandra Denti, Jeffrey L. Cummings, Anuj Guruacharya

    Riassunto Riassunto Mappa Mappa  

• Editorial

  • ·Time to pay attention to sleep for Alzheimer’s disease in women

    Articolo :100624

    Ece Bayram

    Mappa Mappa

• Original articles

  • ·Sleep complaints and genetic risk of Alzheimer’s disease in older women: associations with memory and tau deposition

    Articolo :100581

    Kitty K Lui, Xin Wang, Melanie A Dratva, Ella T. Lifset, Jordan Stiver, Nadine C. Heyworth, Qian Shen, Michael Thomas, Pamela N. DeYoung, Atul Malhotra, Erin E. Sundermann, Sarah J. Banks

    Riassunto Riassunto Mappa Mappa   
  • ·Tetanus, diphtheria and pertussis vaccination and risk for incident dementia among adults with down syndrome

    Articolo :100583

    Kimberly Schiel, Joanne Salas, Anjani Urban, Daniel F. Hoft, Jeffrey F. Scherrer

    Riassunto Riassunto Mappa Mappa   

• Brief report

  • ·Epigenetic aging and blood based neurodegeneration markers in LASI-DAD

    Articolo :100595

    Jung Ki Kim, Thalida E. Arpawong, Bharat Thyagarajan, Jennifer A. Smith, Sithara Vivek, Scott Ratliff, Sharmistha Dey, Jinkook Lee, Eileen M. Crimmins

    Riassunto Riassunto Mappa Mappa   

• Original articles

  • ·Hypertension acts together with Aβ pathology in late-life to promote memory loss

    Articolo :100579

    Lucas U Da Ros, João Pedro Ferrari-Souza, Marco Antônio de Bastiani, Lucas A. Hauschild, Bruna Bellaver, Pamela C.L. Ferreira, Douglas Teixeira Leffa, Guilherme Povala, Firoza Z. Lussier, Mira Chamoun, Gleb Bezgin, Andrea L. Benedet, Nesrine Rahmouni, Arthur C. Macedo, Kaj Blennow, Nicholas Ashton, Henrik Zetterberg, Wyllians Vendramini Borelli, Diogo O. Souza, Tharick A. Pascoal, Pedro Rosa-Neto, Eduardo R. Zimmer, Alzheimer’s Disease Neuroimaging Initiative

    Riassunto Riassunto Mappa Mappa   
  • ·Interaction of diet and physical activity on dementia risk: the Rotterdam study

    Articolo :100594

    Muhammed Lamin Sambou, M. Arfan Ikram, M. Kamran Ikram, Jeremy A. Labrecque, Frank J. Wolters

    Riassunto Riassunto Mappa Mappa   
  • ·Neuropsychiatric symptoms and dementia development: a 15-year population-based study

    Articolo :100596

    Francesca Remelli, Giulia Grande, Serhiy Dekhtyar, Erika J Laukka, Caterina Trevisan, Stefano Volpato, Laura Fratiglioni, Federico Triolo

    Riassunto Riassunto Mappa Mappa   
  • ·Plasma brain-derived p-Tau217 outperforms other p-Tau species in detecting abnormal brain amyloid in an Asian cohort of older people with cerebrovascular disease burden

    Articolo :100615

    Joyce R. Chong, Saima Hilal, Narayanaswamy Venketasubramanian, Michael Schöll, Nicholas J. Ashton, Henrik Zetterberg, Christopher P. Chen, Mitchell K.P. Lai

    Riassunto Riassunto Mappa Mappa   

• Short communication

  • ·Class-level aggregation obscures clinically relevant heterogeneity in anti-amyloid antibody trials: comments on a Cochrane review by individual members of the EADC

    Articolo :100598

    Kristian Steen Frederiksen, Mercè Boada, Lutz Frölich, Milica Kramberger, Nikolaos Scarmeas, Everard Vijverberg, Pieter Jelle Visser, Gunhild Waldemar, Eric Westman, Henrik Zetterberg, Sebastiaan Engelborghs, Frank Jessen

    Mappa Mappa

• Original articles

  • ·Reductions in neuropsychiatric symptoms after lecanemab treatment and their associations with imaging markers of β-amyloid clearance

    Articolo :100600

    Yaping Yan, Daoyan Hu, Linlin Kong, Kaicheng Li, Jun Su, Yingzhe Wu, Hongwei Zhan, Hong Zhang, Yidan Sun, Xiaofeng Dou, Peiyu Huang, Jiong Zhou

    Riassunto Riassunto Mappa Mappa   
  • ·Adapting the spanish healthcare system for disease-modifying treatments in early-stage alzheimer’s disease

    Articolo :100586

    R. Sánchez Valle, A. Lleó Bisa, A. Villarejo Galende, E. Cuartero Rodríguez, J. Escudero-Torrella, N. Bargallo Alabart

    Riassunto Riassunto Mappa Mappa   
  • ·Diagnostic performance of an automated plasma p-tau217 chemiluminescent assay for detecting Aβ pathology in a Chinese memory clinic cohort

    Articolo :100613

    Shuai Chen, Feng-Yu Wang, Rong Li, Chang Fu, Jing-Yu Shao, Yu Shen, Kai Ma, Xiao-Di Hao, Lin Cao, Jun-Ling Xu, Jie-Wen Zhang

    Riassunto Riassunto Mappa Mappa   
  • ·Multimodal biomarker characterization of amnestic objective subtle cognitive decline in aging and preclinical Alzheimer’s disease

    Articolo :100612

    David López-Martos, Raffaele Cacciaglia, Marc Suárez-Calvet, Gemma Salvadó, Mahnaz Shekari, Armand González-Escalante, Marta Milà-Alomà, Anna Brugulat-Serrat, Carolina Minguillon, Matteo Tonietto, Edilio Borroni, Gregory Klein, Clara Quijano-Rubio, Gwendlyn Kollmorgen, Henrik Zetterberg, Kaj Blennow, Juan Domingo Gispert, Oriol Grau-Rivera, Gonzalo Sánchez-Benavides, ALFA study

    Riassunto Riassunto Mappa Mappa   

• Review

  • ·Biomarkers in preclinical and early Alzheimer’s disease in China: a scoping review

    Articolo :100599

    Guoping Peng, Yan Yang, Ying Wang, Sagar Anil Chandekar, Jintai Yu

    Riassunto Riassunto Mappa Mappa   

• Original article

  • ·Association between obstructive sleep apnea severity and glymphatic-related DTI-ALPS alterations in newly diagnosed, Drug-Naïve Alzheimer’s disease

    Articolo :100597

    Wenxue Zheng, Yao Zhou, Yurui Xia, Yiqing Wang

    Riassunto Riassunto Mappa Mappa   

• Review

  • ·Virtual reality-based training in patients with alzheimer's disease: A systematic review and meta-analysis

    Articolo :100590

    Junjie Wang, Can Wu, Kedong Zhu, Xiaoshan Qi, Guiqin Chen

    Riassunto Riassunto Mappa Mappa  

• Original article

  • ·Phenotyping of mild behavioral impairment domains in multi-regional dementia-free older adults of Chinese ethnicity: impulse dyscontrol as the leading domain

    Articolo :100589

    Yingqi Liao, Yaping Zhang, Haoran Zhang, Yan Li, Dylan X. Guan, Yifan Yan, Yuek Ling Chai, Mitchell K.P. Lai, Shifu Xiao, Christopher L.H. Chen, Xin Xu

    Riassunto Riassunto Mappa Mappa   

• Special article

  • ·Income, diet, and cognitive function: observational analyses and candidate metabolomic pathways identified by Mendelian randomization

    Articolo :100582

    Xingguang Zhao, Weijian Wu, Qiaoxuan Zhang, Mengqian Ouyang, Haoyu Luo, Qun Yu, Yingren Mai, Zhiyu Cao, Shaoqing Yang, Mingsong Xu, Jun Liu, Wang Liao

    Riassunto Riassunto Mappa Mappa   

• Original article

  • ·The growing burden of dementia in Asia: Comparative insights from Japan, China, and India

    Articolo :100614

    Chen Zhang, Xuhui Chen, Yongan Sun

    Riassunto Riassunto Mappa Mappa   

• Letters to the editor

  • ·Asia’s dementia burden: from epidemiological description to prevention-oriented neurology

    Articolo :100627

    Haoyang Hu

    Mappa Mappa
  • ·Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE₄ heterozygotes and non-carriers

    Articolo :100587

    Jemma Hazan, Kathy Y. Liu, Robert Howard

    Mappa Mappa
  • ·Hazan J; Liu KY; Howard R. Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE4 heterozygotes and non-carriers. # TJPAD-D-26-00165

    Articolo :100588

    Lutz Froelich

    Mappa Mappa

• 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference, December 1-4, 2025, San Diego, CA (United States) - Conference proceedings

  • ·Welcome to CTAD25 in San Diego!

    Articolo :100616

    Paul Aisen

    
  • ·18th clinical trials on Alzheimer's disease (CTAD) conference, December 1-4, 2025, San Diego, CA (United States) - Conference proceedings - Oral communications

    Articolo :100617

    Mappa Mappa
  • ·18th Conference Clinical Trials Alzheimer’s Disease December 1-4, 2025, San Diego, CA (United States) - Conference proceedings - Posters

    Articolo :100618